Hello there! What can we do for you today?
Feel free to chat with us — we’d love to hear from you!
Anhua Jinhou Biotechnology Co,. Ltd
Business License
Main Products: Magnolia bark extract, Black pepper extract, Chinese prickly ash oleoresin, Tea Camellia seed oil
Company Overview
Anhua Jinhou Biotechnology Co.,Ltd. was established in Hunan China, 2016. It is a high-tech enterprise dedicated to the modern production process of plant extracts. It owns and manages two factories, laboratories and plant bases. Anhua Jinhou Biotechnology Co.,Ltd.’s business scope includes plants extract, essential oil extraction, health care product research and development, production, processing, sales. The main products of factory 1 are Magnolia officinalis extract (Magnolol, Honokiol, Total phenols), Black pepper extract (Piperine, tetrahydropiperine). Factory 2 mainly produces CoenzymeQ10, Nicotinamide Riboside Chloride (NR-CL), β-Nicotinamide Mononucleotide (NMN), Reduced nicotinamide adenine dinucleotide (NADH), etc. Our productions are widely applied in industries like food, nutraceutical, health care products, cosmetics, pharmaceutical, and daily use chemicals and so on. Anhua Jinhou Biotechnology Co.,Ltd. integrates production and sales, with both leading edge sales position occupying market opportunities and two factories guaranteeing supply. The company possesses competent sales team and has established wide-ranging and stable international and domestic sales network and channel. Anhua Jinhou Biotechnology Co.,Ltd. integrates production and sales, with both leading edge sales position occupying market opportunities and two factories guaranteeing supply. The company possesses competent sales team and has established wide-ranging and stable international and domestic sales network and channel.
-
ManufacturerBusiness Type
-
2016Year Established
-
3,000-5,000 square metersFactory Size
-
US$1.5 Million - US$2.5 MillionAnnual Export Value
Featured Products
View All-
Company History1.In 2016, Company Established. 2.In 2017, The first production line was completed and put into operation, which can process 400 tons of magnolia officinalis extract. 3.In 2019, Participated in Shanghai International Pharmaceutical Raw Materials Exhibition (CPHI); Korea International Cosmetics Exhibition; Thailand cosmetics exhibition and other exhibitions 4.In 2020, The second production line was completed and put into operation, which can process 2000 tons of magnolia officinalis extract. Magnolia officinalis extract full specifications of products on the market. 5.In 2020, Set up the second factory Hunan Enzyme Times Biotechnology Co., LTD. 6.In 2021, Successfully obtained a national invention patent, a magnolol extraction method. 7.In 2021, Won the title of high-tech enterprise in Hunan Province, China.
